Momenta, BioFactura team up on biosimilars
By Suzanne Elvidge 22SEP2016
Getting biosimilars right at the manufacturing stage is vitally important, as there must be no clinically meaningful differences between the follow-on biologic and its reference product. Even small changes to cell lines can lead to major changes in how a biologic behaves, including its safety, efficacy and ability to trigger immune reactions. Creating an alliance with a biomanufacturing company… Continue reading
Momenta taps BioFactura’s NS0 cell line tech for biosimilar candidate
By Dan Stanton 21SEP2016
Momenta Pharmaceuticals has partnered on the development of an undisclosed biosimilar using BioFactura’s StableFast biomanufacturing platform… Continue reading
Frederick biotech company gets praise to go with funding
By Nancy Lavin 07APR2016
The city of Frederick is putting its money where its mouth is in supporting the growing biotech industry. The Board of Aldermen on Thursday approved a $10,000 loan for BioFactura to support the company’s relocation and expansion. The city contribution will work in conjunction with a recently announced $50,000 loan from the Maryland Department of Commerce… Continue reading